Tyumen State Medical University

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Stroke1 trial

Phase

• Phase 31 trial

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Amgen1 trial
• Phenomen Pharma1 trial

Running trials

• Recruiting

  Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly

  NCT07068191· Phenomen Pharma· Source

  Contact: Irina Nagibina

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)1 recruiting

Closed trials

• Completed

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· Phase 3· Amgen· Source